SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: Extra Pale who wrote (263)10/10/2001 10:43:34 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 724
 
Hey, hey, hey! An answer!

Thanks!

(plus, 47% of DGI)

If this Orcutt guy is good -- and thus far he looks like a star -- and if the Freedmans actually provide him with incentive, then this should be a big winner. Sure has been a tough wait.



To: Extra Pale who wrote (263)2/18/2002 1:23:08 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 724
 
Mike:

Based on 2nd quarter results, next 12months
Revenue = $60m
COGS = 36
SG&A = 16
R&D = 3

Net Operating Income = $5m or $.74/share
assuming NOI = NI, at a pe of 15x per share value = $11
at pe of 20x per share value = $14.8

Looks a bit conservative following last report, but looked generous following Q3?

How is a guy supposed to look good with such volatility?

:-)

Cheers! Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News